[{"data":1,"prerenderedAt":29},["ShallowReactive",2],{"case-study-nimbus-therapeutics":3},{"data":4},[5],{"slug":6,"company":7,"industry":8,"logo":9,"logoLocal":10,"pdfUrl":11,"quote":12,"quoteAuthor":13,"quoteRole":14,"headline":15,"summary":16,"challenge":17,"solution":18,"results":19,"additionalQuotes":24},"nimbus-therapeutics","Nimbus Therapeutics","Pharma","https:\u002F\u002Fmeet.nanome.ai\u002Fhs-fs\u002Fhubfs\u002Fnimbus-logo.png","\u002F_nuxt\u002Fnimbus.BOoVvy3A.png","\u002Fdownloads\u002Fcase-study-nimbus.pdf","It's like night and day. You can actually see the different amino acid residues the modelers are talking about and how potentially you might want to interact with them via a compound to drive selectivity. It's very impressive.","Rob Svensson","Expert Oncology and Metabolism Biologist, Nimbus","Accelerating drug discovery to create a healthier future","Nimbus Therapeutics uses VR solutions from Nanome and Oculus to help design breakthrough medicines, expecting to save tens of thousands of dollars per year on project costs.","Computational medicinal chemists struggled to share their 3D molecular structure designs with chemists and biologists on their teams using traditional 2D tools.","Nanome ingests structural data and simulation algorithms, turning them into immersive 3D VR visualizations where scientists can physically interact with molecules and collaborate in real time.",[20,21,22,23],"Expects to save tens of thousands of dollars per year on project costs","Discovered a more promising synthetic vector for AMPKβ2 through VR analysis","Enhanced communication between computational and synthetic chemists","Wireless Oculus Quest enables rapid deployment across meeting rooms",[25],{"text":26,"author":27,"role":28},"Nanome with Oculus increases our ability to communicate and it increases our productivity. For a drug company to be running one of its chemotypes based on an idea we discovered in VR, well, there's a lot of money being invested there.","Lewis Whitehead, PhD","Director of Computational Chemistry, Nimbus Therapeutics",1775871861191]